Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3537556

CCN(CC)Cc1cccc(-c2cc(C#N)cc3ncn(-c4ccccc4)c23)c1.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.36
RAD52 P43351 1/20 0.36
BCHE P06276 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
AVPR1B P47901 1/20 0.35
ACHE P22303 1/20 0.34
BACE1 P56817 1/20 0.34
SLC2A1 P11166 1/20 0.34
ELANE P08246 1/20 0.33
GYS1 P13807 1/20 0.33
AOC3 Q16853 1/20 0.33
MET P08581 1/20 0.33
F11 P03951 1/20 0.33
KLKB1 P03952 1/20 0.33
PLK1 P53350 1/20 0.33
PIK3CD O00329 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2656885 0.92 FGFR1 (0.42) FGFR1BCHEGABRA1GABRG2GABRB3
Trifluoroacetic Acid SCHEMBL2660115 0.91 SLC2A1 (0.36) FGFR1ACHEBACE1SLC2A1
Trifluoroacetic Acid SCHEMBL2662668 0.89 PTGDR2 (0.37) FGFR1RAD52GABRA1GABRG2GABRB3
Trifluoroacetic Acid SCHEMBL2659116 0.85 SLC2A1 (0.43) RAD52SLC2A1MET
Trifluoroacetic Acid SCHEMBL3537552 0.83 PLK1 (0.39) FGFR1GABRA1GABRG2GABRB3GABRA5
SCHEMBL2662670 0.83 FFAR1 (0.36) FGFR1GABRA1GABRG2GABRB3GABRA5
SCHEMBL2654636 0.83 FGFR1 (0.41) FGFR1ACHEBACE1METPIK3CD
SCHEMBL2656918 0.81 FGFR1 (0.42) FGFR1GABRA1GABRG2GABRB3GABRA5
SCHEMBL2655351 0.78 FGFR1 (0.39) FGFR1GABRA1GABRG2GABRB3GABRA5
SCHEMBL2656607 0.76 FGFR1 (0.46) FGFR1GABRA1GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7700638-B2 1,5,7-trisubstituted benzimidazole derivatives and their use for modulating the GABAA receptor complex N. V. ORGANON (NL) 2010-04-20 US disclosed
US-20070021482-A1 1,5,7-Trisubstituted benzimidazole derivatives and their use for modulating the gabaa receptor complex N.V. ORGANON (NL) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021482-A1 1,5,7-Trisubstituted benzimidazole derivatives and their use for modulating the gabaa receptor complex GABRB1, GABRA5, GABRB2 FGFR1 2259/4885RAD52 4569/4885BCHE 1024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.